Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews · Musculoskeletal

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Durable remission during additional · adults (age 18 years and older) with refractory GPA ANCA‐associated vasculitis

It is very uncertain whether infliximab changes durable remission during additional compared with rituximab (very low certainty).

1 finding from 1 review

Anti‐cytokine targeted therapies for ANCA‐associated vasculitis 2020 · Cochrane Headline outcomes only
RR 0.22 [0.03, 1.6]
Studies not reported
Very low